Hengrui Pharmaceutical announced that on October 14, 2026, the company will repurchase 60,000 A-shares through the Shanghai Stock Exchange to be used for A-share employee stock ownership plans. This portion of the shares will be held as treasury shares. The price range for this repurchase was 44.88 yuan to 45.05 yuan, and the total transaction amount was 2.6965 million yuan, accounting for 0.001% of the shares already issued before the incident. As of October 14, 2026, the total number of issued shares of the company was 636,648,3424 shares, the total number of shares in stock was 125,188,850 shares, and the total number of issued shares was 637,9002,274 shares.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.